Tokyo, Japan

Katsuhiko Masuda

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Mitsubishi Tanabe Pharma Corporation. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Katsuhiko Masuda. Retrieved from https://idiyas.com/inventor/katsuhiko-masuda-3ummdlhk

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2011

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Katsuhiko Masuda

Introduction

Katsuhiko Masuda is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patent work. His expertise and dedication have positioned him as a valuable asset in the industry.

Latest Patents

Masuda holds a patent for a compound titled "Salt of morpholine compound - (2S)-[4-(Carboxymethyl)thiazol-2-ylthio]-N-{[4-(3,4-dichlorobenzyl)morpholin-2-yl]methyl}acetamide hydrobromide." This invention is notable for its ability to resist easy weight change caused by vapor sorption compared to its free form. It is recognized for being superior as a drug substance in pharmaceutical products and serves as a production intermediate.

Career Highlights

Katsuhiko Masuda is associated with Mitsubishi Tanabe Pharma Corporation, where he continues to advance his research and development efforts. His work has been instrumental in enhancing the efficacy and stability of pharmaceutical compounds.

Collaborations

Masuda has collaborated with notable colleagues, including Shuzo Takeda and Yoshihito Tanaka. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Katsuhiko Masuda's contributions to the pharmaceutical industry through his innovative patents highlight his role as a leading inventor. His work not only advances drug development but also enhances the overall quality of pharmaceutical products.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…